This inventor holds 1 USPTO granted patent. Top assignee: Lupin, Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: **Anand Jagannath Tarage: Innovator in Pharmaceutical Sciences**
Introduction
Anand Jagannath Tarage, based in Pune, India, is an accomplished inventor with a keen focus on pharmaceutical innovations. He has made significant contributions to the field of medicinal chemistry, particularly through his groundbreaking research aimed at developing novel therapeutic agents.
Latest Patents
Anand holds a patent for "Quinolizinone derivatives as PI3K inhibitors". This patent discloses compounds that include their tautomeric forms, stereoisomers, and pharmaceutically acceptable salts. The invention outlines pharmaceutical compositions comprising these compounds and methods to treat or prevent diseases, such as cancer, by inhibiting the PI3K enzyme in patients.
Career Highlights
Anand is currently affiliated with Lupin, Inc., a prominent name in the pharmaceutical industry. His role at the company emphasizes his commitment to advancing healthcare through innovative drug development.
Collaborations
Throughout his career, Anand has collaborated with talented professionals such as Manojkumar Ramprasad Shukla and Nirmal Kumar Jana. These collaborations have fostered a productive environment for research and innovation, leading to promising advancements in pharmaceutical science.
Conclusion
Anand Jagannath Tarage stands out as a notable inventor whose work in the field of PI3K inhibitors holds great potential for addressing critical health challenges, including cancer. His innovative contributions exemplify the impact of focused research in the pharmaceutical arena, paving the way for future breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile